Targeted radiation drug added to standard treatment in bid to stop prostate Cancer's return
Disease control
Completed
This study tested a new approach for men whose prostate cancer returned after initial radiation treatment. It combined a standard internal radiation procedure (brachytherapy) with an experimental targeted radiation drug (177Lu-PSMA). The goal was to see if this combination could …
Phase: PHASE1, PHASE2 • Sponsor: Glenn Bauman • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC